12/23
08:08 am
bmrn
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target raised by analysts at Truist Financial Corporation from $80.00 to $100.00. They now have a "buy" rating on the stock.
Medium
Report
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target raised by analysts at Truist Financial Corporation from $80.00 to $100.00. They now have a "buy" rating on the stock.
12/22
03:19 pm
bmrn
A $4.8 Billion Reason to Buy BioMarin Stock Today [Yahoo! Finance]
Low
Report
A $4.8 Billion Reason to Buy BioMarin Stock Today [Yahoo! Finance]
12/22
03:17 pm
bmrn
BioMarin: Amicus Buyout Sparks My Enthusiasm [Seeking Alpha]
Low
Report
BioMarin: Amicus Buyout Sparks My Enthusiasm [Seeking Alpha]
12/22
01:02 pm
bmrn
BioMarin to Buy Rare Disease Drugmaker Amicus Therapeutics for $4.8B [Yahoo! Finance]
Low
Report
BioMarin to Buy Rare Disease Drugmaker Amicus Therapeutics for $4.8B [Yahoo! Finance]
12/22
12:46 pm
bmrn
BioMarin snaps up Amicus Therapeutics for $4.8bn amid rare disease push [Yahoo! Finance]
Low
Report
BioMarin snaps up Amicus Therapeutics for $4.8bn amid rare disease push [Yahoo! Finance]
12/22
08:02 am
bmrn
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target raised by analysts at HC Wainwright from $55.00 to $60.00. They now have a "neutral" rating on the stock.
Low
Report
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target raised by analysts at HC Wainwright from $55.00 to $60.00. They now have a "neutral" rating on the stock.
12/20
11:59 pm
bmrn
These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More [Yahoo! Finance]
Low
Report
These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More [Yahoo! Finance]
12/20
03:16 pm
bmrn
Key deals this week: Trump Media & Technology, Howard Hughes, BioMarin Pharmaceutical and more [Seeking Alpha]
Low
Report
Key deals this week: Trump Media & Technology, Howard Hughes, BioMarin Pharmaceutical and more [Seeking Alpha]
12/20
08:22 am
bmrn
BioMarin (BMRN) Jumps 17.7% on $5-Billion Merger with Amicus [Yahoo! Finance]
Low
Report
BioMarin (BMRN) Jumps 17.7% on $5-Billion Merger with Amicus [Yahoo! Finance]
12/19
04:40 pm
bmrn
Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today [Yahoo! Finance]
Medium
Report
Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today [Yahoo! Finance]
12/19
01:09 pm
bmrn
These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More [Yahoo! Finance]
Low
Report
These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More [Yahoo! Finance]
12/19
01:02 pm
bmrn
Biotech Bombshell: BioMarin's $4.8B Bet Ignites Amicus Shares in Rare-Disease Power Play [Yahoo! Finance]
Low
Report
Biotech Bombshell: BioMarin's $4.8B Bet Ignites Amicus Shares in Rare-Disease Power Play [Yahoo! Finance]
12/19
11:32 am
bmrn
BioMarin Pharmaceutical Inc. (BMRN) M&A Call Transcript [Seeking Alpha]
Low
Report
BioMarin Pharmaceutical Inc. (BMRN) M&A Call Transcript [Seeking Alpha]
12/19
11:21 am
bmrn
BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping. [Yahoo! Finance]
Low
Report
BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping. [Yahoo! Finance]
12/19
10:59 am
bmrn
BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping. [Barron's]
Low
Report
BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping. [Barron's]
12/19
10:36 am
bmrn
BioMarin Pharmaceutical to Acquire Amicus Therapeutics in $4.8 Billion Deal [Yahoo! Finance]
Low
Report
BioMarin Pharmaceutical to Acquire Amicus Therapeutics in $4.8 Billion Deal [Yahoo! Finance]
12/19
10:04 am
bmrn
Update: BioMarin Pharmaceutical to Acquire Amicus Therapeutics for $4.8 Billion; Shares Jump [Yahoo! Finance]
Low
Report
Update: BioMarin Pharmaceutical to Acquire Amicus Therapeutics for $4.8 Billion; Shares Jump [Yahoo! Finance]
12/19
09:13 am
bmrn
BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet [Yahoo! Finance]
High
Report
BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet [Yahoo! Finance]
12/19
08:45 am
bmrn
BioMarin Pharmaceutical to Acquire Amicus Therapeutics for $4.8 billion [Yahoo! Finance]
High
Report
BioMarin Pharmaceutical to Acquire Amicus Therapeutics for $4.8 billion [Yahoo! Finance]
12/19
08:24 am
bmrn
BioMarin to acquire Amicus Therapeutics for $4.8 billion [CNBC]
High
Report
BioMarin to acquire Amicus Therapeutics for $4.8 billion [CNBC]
12/19
08:00 am
bmrn
BioMarin to acquire rare disease drug developer Amicus for $4.8B [Seeking Alpha]
High
Report
BioMarin to acquire rare disease drug developer Amicus for $4.8B [Seeking Alpha]
12/19
07:51 am
bmrn
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook [Yahoo! Finance]
High
Report
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook [Yahoo! Finance]
12/19
07:45 am
bmrn
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
High
Report
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
12/12
08:33 am
bmrn
Can BioMarin (BMRN) Turn Margin Ambitions Into Strength Amid Rising Rare-Disease Competition? [Yahoo! Finance]
Low
Report
Can BioMarin (BMRN) Turn Margin Ambitions Into Strength Amid Rising Rare-Disease Competition? [Yahoo! Finance]
12/11
10:33 pm
bmrn
Is The Market Mispricing BioMarin After Its Multi Year Share Price Slump In 2025 [Yahoo! Finance]
Low
Report
Is The Market Mispricing BioMarin After Its Multi Year Share Price Slump In 2025 [Yahoo! Finance]